Background
Importance of hepatitis B vaccination monitoring
Participating in hepatitis B vaccination and hepatitis C testing monitoring
Prison Hepatitis B Vaccination Programme Monitoring Reports

Background

The Prison Infection Prevention (PIP) Team was established at the Health Protection Agency to monitor hepatitis B vaccine delivery in prisons in England and Wales. The programme aimed to deliver the hepatitis B vaccine to all prisoners within 31 days of entering the prison establishment.  Where appropriate, all prisoners being received into a prison for a new sentence should be offered hepatitis B immunisation, and if the prisoner accepts the vaccine, the prisoner should receive all the vaccine doses within the first month of reception using the super accelerated course of the hepatitis B vaccine1, 2 (0, 7 and 21 days and booster at 12 months).

The PIP Team collected and collated vaccination data and produced Hepatitis B Vaccination Programme Monitoring Reports for prisons and other stakeholders. This Prison Hepatitis B Vaccination Monitoring Programme ceased on March 31st 2010.  Hepatitis B is still a Prison Health Performance and Quality Indicator (PHPQI) as set out by Offender Health (OH), Department of Health and the NHS are now responsible for monitoring hepatitis B vaccine delivery in prisons. Vaccination data should be reported to the commissioning lead at local primary care trusts (PCTs). Prisons are categorised as red, amber or green according to their progress in implementing the programme.

• Green:
  Hepatitis B quarterly reporting confirms that the prison achieves Hepatitis B vaccine coverage of 80% or more for all new prisoners received into the establishment in the three months prior to the reference date.
• Amber:
  Hepatitis B vaccine coverage of between 50% and 80% for all eligible prisoners received into the establishment in the three months prior to the reference date.
• Red:
  1. The prison does not provide robust quarterly surveillance data from which vaccine coverage can be calculated
  
  OR
  
  2. The prison is achieving Hepatitis B vaccine coverage of less than 50% for all new eligible prisoners received into the establishment in the three months prior to the reference date.

Guidance and templates for reporting are published on our website.

Importance of hepatitis B vaccination monitoring

• Prisons represent a good opportunity to vaccinate hard to reach groups, for example, Injecting Drugs Users that in the community may have poor access to health care.
• The transient nature of prison populations mean the benefits of hepatitis B vaccination extend beyond the prisoners themselves, and into the wider community.
• Data from the Hepatitis B Vaccination Monitoring Programme can be usedby prisons to assess their own progress with vaccination activity;

Participating in hepatitis B vaccination and hepatitis C testing monitoring

Electronic monitoring is available to record your vaccination and testing data through John Hastings, NHS South West: 01823 361347 / John.Hastings@southwest.nhs.uk.

Preliminary Q2 2011 July-Sept Hep B+C Return (Excel Spreadsheet, 170 KB) 
Preliminary Q3 2011-12 Oct-Dec Hep B+C Return (Excel Spreadsheet, 174 KB)

Prison Hepatitis B Vaccination Programme Monitoring Reports

The Prison Infection Prevention (PIP) Team was established at the Health Protection Agency to monitor hepatitis B vaccine delivery in prisons in England and Wales. The PIP Team collected and collated vaccination data from participating prison establishments and produced the Hepatitis B Vaccination Programme Monitoring Reports for prisons and other stakeholders. This Prison Hepatitis B Vaccination Monitoring Programme ceased on March 31st 2010 and responsibility passed to the NHS.

2010 Annual Quarter 1 Report (PDF, 287 KB)

Back To Top

• 2009 Quarterly and Monthly Monitoring Reports
  Added/updated: 26 January 2012
  
• 2008 Monthly Monitoring Reports
  Added/updated: 26 January 2012